Introduction {#sec1}
============

Ovarian cancer is one of the most common malignant tumors in women, accounting for 2.5% of female cancers \[[@B1]\]. About 13,850 women die each year from ovarian cancer; this may be the main causes of cancer death in United States among females \[[@B2],[@B3]\]. Furthermore, the 5-year survival rate with all types of ovarian cancer is about 47% \[[@B2],[@B3]\]. Health education and diet prevention are important ways of preventing ovarian cancer. Vitamin E, also named as tocopherol, contains putative anti-cancer and anti-mutant substances that have long been considered to prevent cancer. It is also a well-known powerful antioxidant, which could protect cells against from oxidative DNA damage and mutagenesis, thereby preventing the onset of certain tumors \[[@B4],[@B5]\]. Previous meta-analyses had been published to explore vitamin E intake on many tumors, such as lung cancer \[[@B6]\], esophageal cancer \[[@B7]\], uterine cervical neoplasm \[[@B8]\] and so on. To our attention, a lot of studies have investigated vitamin E intake from food or from supplement on the risk of ovarian cancer, resulting in inconsistent findings. The reasons for these differences included small sample size, low statistical capacity and/or clinical heterogeneity. To overcome the limitations of individual research and address these inconsistencies, we conducted this meta-analysis to provide a comprehensive overview.

Materials and methods {#sec2}
=====================

Search strategy {#sec2-1}
---------------

To collect studies that met the criteria for this meta-analysis, we reviewed all literature on the relationship between vitamin E and ovarian cancer risk. Literature searches were performed using Web of Science, EMBASE and PubMed databases (up to June 1, 2019). The following key words and subject terms were used in the search: "vitamin E" OR "vitamin\*" OR "tocopherol" combined with "ovarian cancer" OR "ovarian tumor". We also manually screened the bibliography of original research and review articles. The initial qualification is determined independently by the two reviewers. Disagreements between the reviewers are resolved by a third-party reviewer at a consensus meeting.

Inclusion criteria and exclusion criteria {#sec2-2}
-----------------------------------------

To be included in the meta-analysis, these studies must be: (1) case--control, cross-sectional or cohort studies; (2) patients were diagnosed as ovarian cancer; (3) report relative risks (RRs) and 95% confidence intervals (CIs) about vitamin E and ovarian cancer. When two or more articles report the same data, the most recently updated data will be considered. The two reviewers screened the titles and abstracts of the records retrieved from the literature. The full text of the potential related articles is independently searched and evaluated by two reviewers, and the differences in research qualifications are resolved by a third author.

The exclusion criteria were as follows: (1) case reports, conference abstracts, letters, editorials, reviews; (2) overlapping or duplicate studies; (3) irrelevant studies; (4) no available data of RRs and 95%CIs and (5) animal studies.

Data extraction {#sec2-3}
---------------

Two investigators independently extracted these information from all eligible studies selected according to predefined criteria. Data were extracted about the last name of first author, age, study design, country, cases and participants, RR and 95%CI, sources of vitamin E (total vitamin E, vitamin E from food or vitamin E from supplement) and category of vitamin E on ovarian cancer risk.

Statistical analysis {#sec2-4}
--------------------

All statistical analyses were conducted using the STATA software V.12.0 (STATA Corp, College Station, Texas, U.S.A.). We conducted a meta-analysis of the relationship about vitamin E on ovarian cancer risk. Pooled results were expressed as RRs and 95%CIs with a random-effect model \[[@B9]\]. We used Cochran *Q* statistic and *I*² to assess variation and heterogeneity within and between studies \[[@B10]\]. The heterogeneity test was used to evaluate the null hypothesis that all studies evaluated the same effect. When the *Q* test *P* \< 0.05 or *I*² \> 50%, it is suggested that the study may be heterogeneous \[[@B11]\]. Sensitivity analysis was used to explore whether one single study had the essential effect on the overall RRs. To assess publication bias, visual observations using the Egger test \[[@B12]\] and the funnel plot \[[@B13]\] were used. When *P* \< 0.05, the difference was statistically significant.

Results {#sec3}
=======

Studies included in the meta-analysis {#sec3-1}
-------------------------------------

We identified 731 studies using electronic and manual retrieval methods, 394 of which were excluded because they were copies of other reports. Of the remaining 337 articles, 292 articles were excluded after review based on the title and abstract, and 45 were reviewed in full-text. Meanwhile, 31 articles were excluded due to reasons present in [Figure 1](#F1){ref-type="fig"}. Finally, a total of 14 articles \[[@B14]\] involving 4597 cases met the inclusion criteria of this meta-analysis. Five articles were cohort design and the remaining nine articles were case--control design. All the studies come from North America except one from Asia. [Table 1](#T1){ref-type="table"} summarizes some of the basic features of all included studies.

![Flow chart of meta-analysis for exclusion/inclusion of studies](bsr-39-bsr20193311-g1){#F1}

###### Characteristics of each individual study included in our analysis

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study, Year                     Design   Age      Participants, Cases   Country         Source of vitamin E       Category                      RR (95%CI)
  ------------------------------- -------- -------- --------------------- --------------- ------------------------- ----------------------------- -------------------
  Chang et al., 2007              Cohort   \<84     97,275,\              United States   Total vitamin E intake    \>207 versus ≤7 mg/d          1.46(0.76--2.79)
                                                    280                                                                                           

  Cramer et al., 2001             PBCC     \>50     1065,\                United States   Total vitamin E intake    Q5 versus Q1                  0.97(0.64--1.49)
                                                    549                                                                                           

  Fairfield et al., 2001          Cohort   30--55   80,326,\              United States   Total vitamin E intake\   327 IU/day versus 5 IU/day\   0.88(0.61--1.27)\
                                                    301                                   From food                 12 IU/day versus 5 IU/day     1.52(1.04--2.21)

  Fleischauer et al., 2001        HBCC     ≥18      419,\                 United States   Total vitamin E intake\   \>43.5 versus \<11.0 mg/d\    0.59(0.30--1.15)\
                                                    168                                   From food\                \>10.5 versus \<6.5 mg/d\     1.82(0.90--3.69)\
                                                                                          From supplement           \>30 mg/d versus none         0.43(0.26--0.72)

  Gifkins et al., 2012            PBCC     \>21     595,\                 United States   Total vitamin E intake\   \>114.9 versus \<21.7 mg/d\   1.03(0.59--1.78)\
                                                    205                                   From food\                \>11.6 versus \<7.4 mg/d\     0.89(0.45--1.77)\
                                                                                          From supplement           Yes versus no                 1.63(1.02--2.63)

  Kushi et al., 1999              Cohort   55--69   29,083,\              United States   From food                 \>24.4 versus \<6.2 mg/d      0.91(0.56--1.48)
                                                    139                                                                                           

  McCann et al., 2001             HBCC     20--87   1921,\                United States   From food                 \>9.4 versus ≤4.9 mg/d        0.58(0.38--0.88)
                                                    496                                                                                           

  Pan et al. 2004                 PBCC     20--76   2577,\                Canada          From supplement           ≥10 years versus never        0.49(0.30--0.81)
                                                    442                                                                                           

  Salazar-Martinez et al., 2002   HBCC     20--79   713,\                 Mexico          Total vitamin E intake    ≥9.4 versus ≤6.3 mg/d         1.60(0.88--2.95)
                                                    84                                                                                            

  Silvera et al., 2006            Cohort   40--59   89,835,\              Canada          Total vitamin E intake\   \>28 versus \<17 mg/d\        1.24(0.85--1.82)\
                                                    264                                   From food                 \>25 versus \<17 mg/d         0.87(0.57--1.31)

  Terry et al. 2017               PBCC     20--79   1038,\                United States   Total vitamin E intake\   \>25.8 versus \<6.7 mg/d\     0.91(0.61--1.37)\
                                                    406                                   From food\                \>9.1 versus \<4.1 mg/d\      0.90(0.49--1.67)\
                                                                                          From supplement           ≥13.5 mg/d versus never       0.86(0.61--1.20)

  Thomson et al., 2008            Cohort   50--79   133,614,\             United States   Total vitamin E intake\   \>403.2 versus \<7.4 mg/d\    1.22(0.89--1.66)\
                                                    451                                   From food\                \>9.4 versus ≤4.9 mg/d\       1.05(0.71--1.57)\
                                                                                          From supplement           \>200 mg/d versus never       1.12(0.86--1.45)

  Tung et al., 2005               PBCC     45--75   1165,\                United States   Total vitamin E intake    Q4 versus Q1                  0.80(0.56--1.16)
                                                    558                                                                                           

  Zhang et al., 2004              HBCC     18--75   906,\                 China           Total vitamin E intake    ≥38.55 versus ≤23.40 mg/d     0.41(0.24--0.70)
                                                    254                                                                                           
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: CI, confidence intervals; HBCC, hospital-based case--control study; PBCC, population-based case--control study; RR, relative risk.

Total vitamin E intake and ovarian cancer risk {#sec3-2}
----------------------------------------------

Eleven studies \[[@B14],[@B22]\] with 3520 cases reported total vitamin E intake on the risk ovarian cancer. Meta-analysis revealed that high category of total vitamin E intake had no significant effect on the risk of ovarian cancer (RRs = 0.95, 95%CIs = 0.78--1.16, *I*^2^ = 53.2%, *P* ~for\ heterogeneity~ = 0.019) ([Figure 2](#F2){ref-type="fig"}). Four studies were cohort design and seven studies were with case--control design. Subgroup analysis by study design showed that the summary RRs on ovarian cancer risk was 1.14 (95%CIs = 0.94--1.38, *I*^2^ = 0.0%, *P* ~for\ heterogeneity~ = 0.417) in cohort studies and 0.84 (95%CIs = 0.64--1.11, *I*^2^ = 55.6%, *P* ~for\ heterogeneity~ = 0.036) in case--control studies. Meanwhile, we further explore the association between ovarian cancer and geographic location. The results suggested that total vitamin E intake is not associated with the risk of ovarian cancer in North America (RRs = 1.02, 95%CIs = 0.88--1.19, *I*^2^ = 16.8%, *P* ~for\ heterogeneity~ = 0.288).

![The forest plot about total vitamin E intake, vitamin E intake from food and vitamin E intake from supplement on ovarian cancer risk](bsr-39-bsr20193311-g2){#F2}

Vitamin E intake from food only and ovarian cancer risk {#sec3-3}
-------------------------------------------------------

Eight studies \[[@B16],[@B23]\] with 2430 cases about vitamin E intake from food only on ovarian cancer risk were included. Overall, the summary RRs on ovarian cancer risk was 0.99 (95%CIs = 0.77--1.27, *I*^2^ = 52.8%, *P* ~for\ heterogeneity~ = 0.038) in vitamin E intake from food only ([Figure 2](#F2){ref-type="fig"}). Four studies were cohort design and the remaining four studies were with case--control design. Subgroup analysis by study design showed high category of vitamin E intake from food only had no significant association on ovarian cancer risk either in cohort studies (RRs = 1.08, 95%CIs = 0.83--1.40, *I*^2^ = 35.9%, *P* ~for\ heterogeneity~ = 0.197) or in case--control studies (RRs = 0.91, 95%CIs = 0.57--1.46, *I*^2^ = 60.8%, *P* ~for\ heterogeneity~ = 0.054).

Vitamin E intake from supplement only and ovarian cancer risk {#sec3-4}
-------------------------------------------------------------

Five studies \[[@B17],[@B18],[@B21],[@B24],[@B25]\] with 1672 cases reported vitamin E intake from supplement only on the risk of ovarian cancer. Overall, the summary RRs of vitamin E intake from supplement only on ovarian cancer risk was 0.82 (95%CIs = 0.54--1.25, *I*^2^ = 82.3%, *P* ~for\ heterogeneity~ \< 0.001).

Publication bias and sensitivity analysis {#sec3-5}
-----------------------------------------

To assess publication bias, Begg's test was conducted. After the analysis is complete, we did not detect any significant publication bias in total vitamin E intake (*P* = 0.620), in vitamin E intake from food only (*P* = 0.876) and in vitamin E intake from supplement only (*P* = 0.365). [Figure 3](#F3){ref-type="fig"} shows the funnel plot about total vitamin E intake and ovarian cancer risk. Sensitivity analyses indicated that no singly study had essential effect on the overall results.

![Funnel plot for the analysis of publication bias between total vitamin E intake and ovarian cancer risk](bsr-39-bsr20193311-g3){#F3}

Discussion {#sec4}
==========

Numerous of studies about vitamin E intake and ovarian cancer risk have been published, with conflicting results. We therefore conducted the present study to clarify whether high category of total vitamin E intake, vitamin E intake from food and vitamin E intake from supplement had some effective on the development of ovarian cancer. A total of 14 papers involving 4597 ovarian cancer cases were used in the present study. Pooled results suggested that high category of total vitamin E intake, vitamin E intake from food only and vitamin E intake from supplement only are not associated with the risk of ovarian cancer. Subgroup analyses by geographic location and study design in total vitamin E intake and subgroup analysis by study design in vitamin E intake from food only obtained consistent results with overall result. These results of the present study suggested to clinicians and researchers that there is no need to supplement vitamin E or intentionally eat more vitamin E.

Between-study heterogeneity existed in our study, which may affect the conclusions of the meta-analysis, although random effects model have been carried out. We used meta-regression to explore the potential heterogeneity. To our attention, geographic location may be a covariate for this high heterogeneity in total vitamin E intake. When we performed the subgroup analysis by geographic location, the *I*^2^ was reduced to 16.8% in North America populations and no analysis for Asia due to only one study from Asia. The result was not changed in North America. We did not detect any other influence factors on this high heterogeneity in total vitamin E intake, vitamin E intake from food and vitamin E intake from supplement.

Previous review by Koushik et al. \[[@B28]\] had explored the association about vitamin E intake on ovarian cancer risk from Pooling Project investigations of ovarian cancer risk. They concluded that consumption of vitamin E did not play a major role in ovarian cancer risk. Another review published by Crane et al. \[[@B29]\] concluded that no association was demonstrated for vitamin E intake on ovarian cancer risk while only included three papers. Results in the current meta-analysis were consistent with the previous reviews. Although our study did not obtain a positive result, we included more studies than the above-mentioned reviews. Furthermore, we also explored the association about total vitamin E intake, vitamin E intake from food and vitamin E intake from supplement on ovarian cancer risk, respectively. Even though, trial sequential analysis should be performed to see if more investigations were needed \[[@B30]\].

Some limitations should be stated in this meta-analysis. First, any literature-based review and meta-analysis are facing a major threat, namely reporting bias (only recruiting published English literature). Second, the sample size of some studies is relatively small. Third, almost all the included studies come from North America, and the results in our study are suitable for North America only. Therefore, to explore the relationship about vitamin E on the risk of ovarian cancer, more studies with other countries are warranted to further confirm this result. There is no doubt that the limitations mentioned above may affect our final conclusions. However, this meta-analysis also has its advantages. To the best of our knowledge, our meta-analysis is the comprehensive evidence to provide vitamin E intake on ovarian cancer risk. Similarly, compared with individual studies, our data on the relationship between vitamin E intake and ovarian cancer risk, due to the results of multiple independent analysis, improved statistical power and resolution, resulting in higher accuracy. However, given the limitations described above, further research is needed to address bias, confusion and opportunity.

Conclusions {#sec5}
===========

In conclusions, the findings of this meta-analysis indicated that high intake of vitamin E from food or vitamin E supplement had no significant effect on the risk of ovarian cancer. More studies are required to further explore these associations due to some limitations existed in our study.
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